Updated Jul 16, 2026
Wilson Martin has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $126K.
Martin Wilson serves as the General Counsel for Rocket Pharmaceuticals, Inc., a biopharmaceutical company focused on developing gene therapies for rare pediatric diseases. He has been involved in multiple SEC filings related to the company, indicating a significant role in its legal and compliance matters.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-21 | RCKT | ROCKET PHARMACEUTICALS, INC. | S — Open-market sale | 662 | $3.01 | $2K |
| 2026-05-14 | RCKT | ROCKET PHARMACEUTICALS, INC. | S — Open-market sale | 3.4K | $3.61 | $12K |
| 2026-02-20 | RCKT | ROCKET PHARMACEUTICALS, INC. | S — Open-market sale | 1.4K | $3.34 | $5K |
| 2026-02-18 | RCKT | ROCKET PHARMACEUTICALS, INC. | S — Open-market sale | 12.3K | $3.31 | $41K |
| 2026-02-13 | RCKT | ROCKET PHARMACEUTICALS, INC. | A — Grant or award | 311.8K | $0.00 | |
| 2025-09-08 | RCKT | ROCKET PHARMACEUTICALS, INC. | A — Grant or award | 150.0K | $0.00 | |
| 2025-08-18 | RCKT | ROCKET PHARMACEUTICALS, INC. | S — Open-market sale | 588 | $3.00 | $2K |
| 2025-08-18 | RCKT | ROCKET PHARMACEUTICALS, INC. | S — Open-market sale | 1.0K | $3.06 | $3K |
| 2025-08-14 | RCKT | ROCKET PHARMACEUTICALS, INC. | S — Open-market sale | 12.1K | $3.02 | $37K |
| 2025-05-20 | RCKT | ROCKET PHARMACEUTICALS, INC. | S — Open-market sale | 587 | $6.45 | $4K |
| 2025-05-16 | RCKT | ROCKET PHARMACEUTICALS, INC. | S — Open-market sale | 946 | $6.53 | $6K |
| 2024-11-25 | RCKT | ROCKET PHARMACEUTICALS, INC. | S — Open-market sale | 1.2K | $13.05 | $15K |
Martin Wilson serves as the General Counsel for Rocket Pharmaceuticals, Inc., a biopharmaceutical company focused on developing gene therapies for rare pediatric diseases. He has been involved in multiple SEC filings related to the company, indicating a significant role in its legal and compliance matters.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 10 open-market sales ($126K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Wilson Martin profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.